Hayes M Dansky
Overview
Explore the profile of Hayes M Dansky including associated specialties, affiliations and a list of published articles.
Author names and details appear as published. Due to indexing inconsistencies, multiple individuals may share a name, and a single author may have variations. MedLuna displays this data as publicly available, without modification or verification
Snapshot
Snapshot
Articles
28
Citations
1150
Followers
0
Related Specialties
Related Specialties
Top 10 Co-Authors
Top 10 Co-Authors
Published In
Published In
Affiliations
Affiliations
Soon will be listed here.
Recent Articles
1.
Dewey F, Gusarova V, Dunbar R, ODushlaine C, Schurmann C, Gottesman O, et al.
N Engl J Med
. 2017 May;
377(3):211-221.
PMID: 28538136
Background: Loss-of-function variants in the angiopoietin-like 3 gene (ANGPTL3) have been associated with decreased plasma levels of triglycerides, low-density lipoprotein (LDL) cholesterol, and high-density lipoprotein (HDL) cholesterol. It is not...
2.
McLaren D, Previs S, Phair R, Stout S, Xie D, Chen Y, et al.
J Lipid Res
. 2015 Dec;
57(3):398-409.
PMID: 26658238
Studies in lipoprotein kinetics almost exclusively rely on steady-state approaches to modeling. Herein, we have used a non-steady-state experimental design to examine the role of cholesteryl ester transfer protein (CETP)...
3.
Krauss R, Pinto C, Liu Y, Johnson-Levonas A, Dansky H
J Clin Lipidol
. 2015 Feb;
9(1):93-102.
PMID: 25670366
Objectives: Our aim was to assess the effects of the cholesteryl ester transfer protein (CETP) inhibitor anacetrapib and atorvastatin, both as monotherapy and in combination, on particle concentrations of low-density...
4.
Roddy T, McLaren D, Chen Y, Xie D, Dunn K, Kulick A, et al.
Eur J Pharmacol
. 2014 Apr;
740:410-6.
PMID: 24769414
Inhibition of cholesteryl ester transfer protein (CETP) has been vigorously pursued as a potential therapy to treat patients who are at an elevated risk for coronary artery disease. Anacetrapib, a...
5.
Gotto Jr A, Kher U, Chatterjee M, Liu Y, Li X, Vaidya S, et al.
J Cardiovasc Pharmacol Ther
. 2014 Apr;
19(6):543-9.
PMID: 24737712
Anacetrapib is a cholesteryl ester transfer protein (CETP) inhibitor that has previously been shown to reduce low-density lipoprotein cholesterol (LDL-C) and raise high-density lipoprotein cholesterol (HDL-C) in patients with or...
6.
Gotto Jr A, Cannon C, Li X, Vaidya S, Kher U, Brinton E, et al.
Am J Cardiol
. 2013 Nov;
113(1):76-83.
PMID: 24188894
The aim of this study was to assess the effects on lipids and safety during a 12-week reversal period after 18 months of treatment with anacetrapib. The cholesteryl ester transfer...
7.
Davidson M, Liu S, Barter P, Brinton E, Cannon C, Gotto Jr A, et al.
J Lipid Res
. 2012 Nov;
54(2):467-72.
PMID: 23172660
Estimation of low-density lipoprotein cholesterol (LDL-C) using the Friedewald (FR) formula is often inaccurate when triglycerides are elevated or VLDL particle composition is altered. We hypothesized that LDL-C estimation by...
8.
Myers K, Rudd J, Hailman E, Bolognese J, Burke J, Pinto C, et al.
JACC Cardiovasc Imaging
. 2012 Jan;
5(1):38-45.
PMID: 22239891
Objectives: A prospective, multicenter (18)fluorine-fluorodeoxyglucose ((18)F-FDG) positron emission tomography (PET)/computed tomography (CT) imaging study was performed to estimate the correlations among arterial FDG uptake and atherosclerotic plaque biomarkers in patients...
9.
Krauss R, Wojnooski K, Orr J, Geaney J, Pinto C, Liu Y, et al.
J Lipid Res
. 2011 Dec;
53(3):540-547.
PMID: 22180633
We investigated the effects of the cholesteryl ester (CE) transfer protein inhibitor anacetrapib (ANA) on plasma lipids, lipoprotein subfraction concentrations, and lipoprotein composition in 30 healthy individuals. Participants (n =...
10.
Dansky H, Bloomfield D, Gibbons P, Liu S, McCrary Sisk C, Tribble D, et al.
Am Heart J
. 2011 Oct;
162(4):708-16.
PMID: 21982664
This report describes the lipid and safety data collected during an off-drug period that followed 8 weeks of treatment with the cholesteryl ester transfer protein inhibitor, anacetrapib (ANA). A total...